Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year ...

Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem ...

Venus Remedies secures EU GMP renewal from Infarmed, strengthens European market presence: Our Bureau, Bengaluru Wednesday, January 22, 2025, 15:30 Hrs [IST] Venus Remedies has an ...

The medical cannabis product is launched under the brand IndiMed and manufactured at Aurora's EU-GMP facility in Leuna, Germany.

The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, ...

The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...

Canadian shares may open flat or with a slightly negative bias on Thursday, tracking weak crude oil prices and amid concerns about ...

Venues remedies rallied 5.30% to Rs 310.95 after the company successfully renewed its European good manufacturing practices (GMP) certification by infarmed, the national health authority of Medicines ...

Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and ...

EQS-News: SynBiotic SE / Key word (s): Mergers & Acquisitions/Strategic Company Decision SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 10.01.2025 / 11:44 ...